Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 4/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.37 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23177538 | 0.95 | PLA2G2A (0.36) | PLA2G2APLA2G4APLA2G10CASP3SENP7 | |
| SCHEMBL23177407 | 0.90 | PLA2G2A (0.32) | PLA2G2APLA2G4APLA2G10NPY5R | |
| SCHEMBL18158870 | 0.86 | KDM4E (0.42) | PLA2G2APLA2G4APLA2G10CASP3SENP7 | |
| SCHEMBL16482388 | 0.82 | L3MBTL1 (0.43) | PLA2G2APLA2G4APLA2G10NPY5R | |
| SCHEMBL16310857 | 0.82 | PLA2G2A (0.35) | PLA2G2APLA2G4APLA2G10CASP3SENP7 | |
| SCHEMBL17481907 | 0.81 | L3MBTL1 (0.42) | PLA2G2APLA2G4APLA2G10NPY5R | |
| SCHEMBL25752906 | 0.81 | PLA2G2A (0.36) | PLA2G2APLA2G4APLA2G10CASP3SENP7 | |
| SCHEMBL25752907 | 0.81 | PLA2G2A (0.36) | PLA2G2APLA2G4APLA2G10CASP3SENP7 | |
| SCHEMBL23177251 | 0.81 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL17463251 | 0.81 | KDM4E (0.39) | PLA2G2APLA2G4APLA2G10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11647669-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-09 | — | — | US | disclosed |
| US-11647669-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-09 | — | — | US | disclosed |
| US-20210098720-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11647669-B2 | Heterocyclic compound and organic light-emitting device including the same | CRY1, CYP1A1, CRY2 | PLA2G2A 4492/4885PLA2G4A 4518/4885PLA2G10 4628/4885 |
| US-20210098720-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CYP1A1, CRY2 | PLA2G2A 4492/4885PLA2G4A 4518/4885PLA2G10 4628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.